| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,348 |
28,007 |
$5.76M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,850 |
25,420 |
$5.71M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,645 |
12,516 |
$4.42M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,458 |
6,213 |
$1.33M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
3,642 |
3,235 |
$1.09M |
| A0425 |
Ground mileage, per statute mile |
4,915 |
4,142 |
$1.06M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,696 |
1,626 |
$1.04M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,367 |
8,376 |
$774K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,960 |
5,210 |
$647K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,916 |
2,253 |
$630K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,853 |
1,782 |
$561K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,307 |
2,210 |
$510K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,802 |
1,633 |
$505K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,287 |
3,147 |
$451K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,288 |
1,608 |
$407K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,749 |
5,253 |
$394K |
| 80053 |
Comprehensive metabolic panel |
21,339 |
19,230 |
$347K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,045 |
3,597 |
$324K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,520 |
1,158 |
$316K |
| 71045 |
Radiologic examination, chest; single view |
3,560 |
3,316 |
$282K |
| 87631 |
|
1,497 |
1,454 |
$271K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,553 |
20,222 |
$261K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,009 |
1,932 |
$251K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,339 |
3,092 |
$234K |
| 71046 |
Radiologic examination, chest; 2 views |
2,445 |
2,324 |
$221K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,977 |
4,245 |
$214K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
901 |
899 |
$199K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
466 |
447 |
$193K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,004 |
7,778 |
$182K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
1,279 |
1,221 |
$181K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,558 |
2,323 |
$174K |
| 73562 |
|
1,060 |
964 |
$170K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,900 |
2,864 |
$140K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,899 |
2,863 |
$140K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,161 |
3,135 |
$123K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,825 |
1,747 |
$121K |
| 59025 |
Fetal non-stress test |
552 |
359 |
$113K |
| 73610 |
|
690 |
638 |
$112K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,533 |
4,421 |
$111K |
| 73030 |
|
662 |
621 |
$99K |
| 81513 |
|
512 |
504 |
$98K |
| 84484 |
|
3,530 |
2,923 |
$96K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,215 |
861 |
$84K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
142 |
142 |
$80K |
| 80306 |
|
2,267 |
2,147 |
$75K |
| G0378 |
Hospital observation service, per hour |
119 |
106 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
10,254 |
9,375 |
$71K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
393 |
384 |
$66K |
| 73130 |
|
602 |
521 |
$64K |
| 73630 |
|
575 |
540 |
$63K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,584 |
5,215 |
$61K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,989 |
2,671 |
$60K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,286 |
5,208 |
$60K |
| 76830 |
Ultrasound, transvaginal |
369 |
360 |
$59K |
| 81001 |
|
7,666 |
7,150 |
$55K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,558 |
2,434 |
$55K |
| 81025 |
|
3,946 |
3,743 |
$55K |
| 83690 |
|
4,583 |
4,154 |
$53K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
310 |
303 |
$52K |
| 84439 |
|
4,316 |
4,232 |
$52K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
344 |
335 |
$51K |
| 87081 |
|
3,375 |
3,317 |
$46K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,336 |
1,321 |
$44K |
| 86803 |
|
2,247 |
2,224 |
$43K |
| 93976 |
|
192 |
188 |
$43K |
| 72100 |
|
241 |
237 |
$42K |
| 86780 |
|
2,082 |
2,051 |
$38K |
| 73110 |
|
356 |
323 |
$38K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
115 |
112 |
$38K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,005 |
968 |
$37K |
| 83605 |
|
2,024 |
1,774 |
$35K |
| J3490 |
Unclassified drugs |
8,699 |
3,979 |
$35K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
314 |
308 |
$35K |
| 81003 |
|
6,456 |
6,068 |
$34K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
949 |
944 |
$34K |
| A0998 |
Ambulance response and treatment, no transport |
451 |
426 |
$32K |
| 87077 |
|
2,177 |
2,033 |
$31K |
| 80061 |
Lipid panel |
1,829 |
1,800 |
$30K |
| 82077 |
|
1,690 |
1,446 |
$30K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
51 |
47 |
$30K |
| 83735 |
|
2,458 |
2,033 |
$29K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,973 |
3,558 |
$27K |
| 81514 |
|
80 |
80 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
698 |
687 |
$26K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
446 |
445 |
$26K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
171 |
159 |
$25K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
525 |
517 |
$25K |
| 85027 |
|
2,503 |
2,404 |
$24K |
| 87481 |
|
553 |
532 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,686 |
1,574 |
$23K |
| 87040 |
|
849 |
583 |
$23K |
| 96376 |
|
521 |
398 |
$23K |
| 72110 |
|
154 |
151 |
$22K |
| 87186 |
|
1,460 |
1,359 |
$21K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
320 |
296 |
$18K |
| 85379 |
|
824 |
792 |
$18K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
27 |
25 |
$17K |
| 86850 |
|
1,014 |
942 |
$16K |
| 36000 |
|
782 |
742 |
$16K |
| 74018 |
|
134 |
129 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,049 |
969 |
$16K |
| 87650 |
|
461 |
455 |
$15K |
| 85610 |
|
2,211 |
1,860 |
$14K |
| 93041 |
|
215 |
210 |
$14K |
| 86696 |
|
530 |
528 |
$14K |
| 82962 |
|
2,052 |
1,323 |
$14K |
| 83880 |
|
359 |
334 |
$13K |
| 97161 |
|
241 |
235 |
$13K |
| 90715 |
|
482 |
474 |
$13K |
| 84702 |
|
450 |
369 |
$12K |
| 86900 |
|
1,149 |
1,052 |
$10K |
| 87430 |
|
479 |
470 |
$10K |
| 80143 |
|
438 |
414 |
$10K |
| 81002 |
|
2,779 |
1,937 |
$10K |
| 80179 |
|
436 |
414 |
$10K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
16 |
14 |
$9K |
| 86695 |
|
529 |
527 |
$9K |
| 86787 |
|
508 |
499 |
$9K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,080 |
2,359 |
$9K |
| 86762 |
|
402 |
396 |
$8K |
| 0225U |
|
13 |
13 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,416 |
2,233 |
$8K |
| 84153 |
|
318 |
313 |
$8K |
| 87340 |
|
520 |
514 |
$8K |
| 87653 |
|
141 |
137 |
$7K |
| 86901 |
|
1,150 |
1,052 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
125 |
122 |
$7K |
| 86140 |
|
979 |
922 |
$7K |
| 83655 |
|
355 |
352 |
$6K |
| 29125 |
|
24 |
24 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
553 |
432 |
$6K |
| 87660 |
|
196 |
194 |
$5K |
| 87510 |
|
191 |
189 |
$5K |
| 87480 |
|
193 |
190 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
95 |
94 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,282 |
1,162 |
$4K |
| 82728 |
|
226 |
223 |
$4K |
| 97162 |
|
85 |
74 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
17 |
17 |
$4K |
| 73080 |
|
28 |
27 |
$4K |
| 70486 |
|
13 |
13 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
624 |
540 |
$4K |
| 82570 |
|
597 |
562 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
24 |
24 |
$4K |
| 82607 |
|
185 |
181 |
$4K |
| 85652 |
|
486 |
456 |
$4K |
| 80050 |
General health panel |
261 |
260 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
205 |
197 |
$4K |
| 93226 |
|
16 |
15 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,295 |
2,086 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
70 |
69 |
$3K |
| 73502 |
|
27 |
27 |
$3K |
| 82043 |
|
398 |
391 |
$3K |
| 85014 |
|
719 |
667 |
$3K |
| 90670 |
|
212 |
210 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
686 |
660 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
14 |
12 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
25 |
25 |
$2K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
54 |
54 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
41 |
15 |
$2K |
| 85018 |
|
567 |
553 |
$2K |
| 97750 |
|
52 |
50 |
$2K |
| 80076 |
|
142 |
136 |
$2K |
| 82950 |
|
247 |
246 |
$2K |
| 97602 |
|
34 |
12 |
$2K |
| 83540 |
|
172 |
168 |
$2K |
| 82550 |
|
154 |
150 |
$1K |
| 83550 |
|
126 |
122 |
$1K |
| 76857 |
|
12 |
12 |
$1K |
| 90461 |
|
25 |
14 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
469 |
411 |
$1K |
| 86694 |
|
56 |
56 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
581 |
493 |
$996.72 |
| 73090 |
|
16 |
13 |
$949.40 |
| 85730 |
|
102 |
96 |
$881.07 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
33 |
28 |
$824.38 |
| 84403 |
|
27 |
26 |
$818.78 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$793.76 |
| 84100 |
|
86 |
56 |
$792.08 |
| 80074 |
|
12 |
12 |
$783.67 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
341 |
341 |
$777.62 |
| 87807 |
|
37 |
35 |
$759.83 |
| 94760 |
|
70 |
61 |
$738.12 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
202 |
186 |
$622.95 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
34 |
12 |
$607.78 |
| 82274 |
|
26 |
26 |
$518.93 |
| 82670 |
|
12 |
12 |
$515.01 |
| 87070 |
|
42 |
37 |
$452.19 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
224 |
213 |
$443.57 |
| 90656 |
|
24 |
24 |
$252.30 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
32 |
26 |
$248.45 |
| 82272 |
|
54 |
50 |
$248.19 |
| 86038 |
|
12 |
12 |
$246.97 |
| 82140 |
|
14 |
13 |
$238.78 |
| 87205 |
|
43 |
37 |
$235.28 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
28 |
28 |
$231.03 |
| 82150 |
|
22 |
21 |
$228.91 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
118 |
117 |
$227.72 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
16 |
16 |
$168.18 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
55 |
54 |
$125.12 |
| S0028 |
Injection, famotidine, 20 mg |
44 |
40 |
$83.16 |
| G0008 |
Administration of influenza virus vaccine |
51 |
51 |
$63.87 |
| J3411 |
Injection, thiamine hcl, 100 mg |
14 |
12 |
$47.02 |
| J2060 |
Injection, lorazepam, 2 mg |
13 |
12 |
$43.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
51 |
50 |
$36.17 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
13 |
$30.28 |
| 90686 |
|
16 |
16 |
$12.11 |